HCT
Showing 26 - 50 of 1,347
Hematologic Malignancy Trial in Durham (Exercise training)
Recruiting
- Hematologic Malignancy
- Exercise training
-
Durham, North CarolinaDuke Adult Blood and Marrow Transplant Clinic
Dec 16, 2022
Acute Myeloid Leukemia (AML) Trial in Charlotte (Allogeneic HCT, Consolidation chemo)
Terminated
- Acute Myeloid Leukemia (AML)
- Allogeneic HCT
- Consolidation chemotherapy
-
Charlotte, North CarolinaLevine Cancer Institute
Apr 19, 2022
Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)
Recruiting
- Primary CNS Lymphoma
- Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
-
Moscow, Russian FederationNathional Medical Research Center for Hematology
Jun 16, 2022
Non-Hodgkin Lymphoma Trial in Cologne (Tafasitamab, Lenalidomide, Rituximab)
Not yet recruiting
- Non-Hodgkin Lymphoma
- Tafasitamab
- +3 more
-
Cologne, GermanyUniversity of Cologne
Oct 14, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Biphenotypic Acute Leukemia Trial in Tampa (Fludarabine, Melphalan, Total
Active, not recruiting
- Acute Myeloid Leukemia
- +17 more
- Fludarabine
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Brisbane, California
- +4 more
Jul 18, 2022
Cytomegalovirus Infection Trial in Boston (mRNA-1647, Placebo)
Not yet recruiting
- Cytomegalovirus Infection
- mRNA-1647
- Placebo
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 4, 2023
Hypertension Trial in Brazil (candesartan cilexetil + chlorthalidone + amlodipine, Exforge HCT® (valsartan 160mg +
Not yet recruiting
- Hypertension
- candesartan cilexetil + chlorthalidone + amlodipine
- Exforge HCT® (valsartan 160mg + hydrochlorothiazide 12.5mg + amlodipine 5mg)
-
Rio Branco, AC, Brazil
- +21 more
Jun 26, 2023
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Orca-Q
-
Gainesville, FloridaUniversity of Florida
Aug 26, 2022
Head Trauma Trial in Chapel Hill (Stationary Head CT (s-HCT))
Not yet recruiting
- Head Trauma
- Stationary Head CT (s-HCT)
-
Chapel Hill, North CarolinaUNC Hospitals
Aug 16, 2022
Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul
Active, not recruiting
- Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
Sleep Disturbance, Sleep Disorder Trial in Tampa (mHealth Stepped-care Intervention, Educational Control Condition,
Recruiting
- Sleep Disturbance
- Sleep Disorder
- mHealth Stepped-care Intervention
- +5 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 10, 2022
Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)
Not yet recruiting
- Bone Marrow Transplant Complications
- Hematologic Malignancy
- CARE Application
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Feb 1, 2023
Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))
Recruiting
- Hematologic Malignancy
- B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
-
Duarte, CaliforniaCity of Hope
Oct 20, 2023
Allogeneic Hematopoietic Cell Transplantation For Classical
Active, not recruiting
- Lymphoma
- Non-Interventional
-
Princeton, New Jersey
- +1 more
Mar 14, 2022
Graft-versus-host Disease Trial in Milwaukee (Cyclophosphamide, Tacrolimus, Mycophenolate Mofetil)
Not yet recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +3 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Jan 26, 2023
Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Cytomegalovirus, Donor Trial in Columbus (Allogeneic
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation Recipient
- +3 more
- Allogeneic Cytomegalovirus-Specific Cytotoxic T lymphocytes
-
Columbus, Ohio
- +1 more
Apr 20, 2022
Hematologic Malignancy Trial in Tuebingen,, Tuebingen (CD45RA depleted donor lymphocyte infusion (DLI))
Recruiting
- Hematologic Malignancy
- CD45RA depleted donor lymphocyte infusion (DLI)
-
Tuebingen,, Germany
- +1 more
Jul 13, 2023
Cancer Trial in Boston (CARE, Standard Transplant Care)
Active, not recruiting
- Cancer
- CARE
- Standard Transplant Care
-
Boston, MassachusettsMassachusetts General Hospital
Jan 24, 2023
Hematopoietic Stem Cell Transplantation, Hematologic Diseases, Sexual Dysfunction Trial in Boston (Enhanced Standard Care,
Recruiting
- Hematopoietic Stem Cell Transplantation
- +2 more
- Enhanced Standard Care
- Multimodal Intervention to Address Sexual Dysfunction
-
Boston, MassachusettsMassachusetts General Hospital
Aug 23, 2022
Multiple Myeloma Trial in Tampa (biological, procedure, drug)
Active, not recruiting
- Multiple Myeloma
- Survivin Vaccine
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022
Stem Cell Transplant Trial in Scottsdale (Digital stories, Informational videos)
Completed
- Stem Cell Transplant
- Digital stories
- Informational videos
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jul 18, 2022
Other Cancer Trial in Boston (ruxolitinib)
Recruiting
- Other Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Hematologic Malignancy, Myeloproliferative Disorder Trial in New York (Isavuconazole)
Completed
- Hematologic Malignancy
- Myeloproliferative Disorder
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Nov 15, 2021